Clinical Context
A typical patient is an adult with a chronic inflammatory condition such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, or Crohn disease who requires subcutaneous biologic therapy with adalimumab. The patient presents to an outpatient infusion clinic, specialty pharmacy clinic, or a physician office for administration counseling, medication dispensing verification, and observation for adverse reaction after self-injection training or clinic-administered injection. The clinical workflow includes medication order verification, confirmation of diagnosis and prior authorization status, review of allergies and infection risk (including screening for active infections and tuberculosis where indicated), documentation of lot number and expiration, preparation of the dose (calculated in milligrams), administration of the subcutaneous injection, monitoring for 15–30 minutes for immediate hypersensitivity, and documentation of the service and medication details in the medical record and the billing system using the HCPCS code J0139 billed per milligram of adalimumab supplied.
Coding Specifications
| Modifier | Description | When to Use |
|---|
00 | No modifier (default) | Use when no special circumstances apply; standard billing for the medication. |
22 | Increased procedural services | Use when significantly greater work is required for drug preparation or administration beyond typical complexity (rare for standard subcutaneous injection).
23 | Unusual anesthesia | Not typically used with J0139; only when unusual anesthesia services are furnished related to drug administration.
52 | Reduced services | Use when a partially reduced service is provided (for example, partial dose due to adverse event requiring early termination of administration).
53 | Discontinued procedure | Use when administration was started but discontinued for documented medical reasons before completion.
62 | Two surgeons | Not commonly used for medication administration; applicable if two surgeons are involved in a related procedural service.
78 | Unplanned return to operating/procedure room for a related procedure during postoperative period | Rare for subcutaneous injection; used only if a related unplanned surgical/procedural return occurs.
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare patients | Use to indicate the service was performed by an authorized non-physician practitioner when required by payor rules.
CQ | Service furnished by a resident without an attending physician present — primary care exception | Use when applicable per Medicare billing rules for resident-provided services.
QX | CRNA service with medical direction by a physician | Not typically applicable to J0139; included if anesthesia services are billed concurrently.
| Taxonomy Code | Specialty | Notes |
|---|
208000000X | Family Medicine | Commonly manages chronic inflammatory diseases and prescribes adalimumab. |
207R00000X | Internal Medicine | Primary prescribers for chronic autoimmune conditions requiring biologic therapy.
207L00000X | Rheumatology | Specialty most frequently initiating and managing adalimumab therapy for rheumatologic indications.
207P00000X | Dermatology | Prescribes adalimumab for dermatologic indications such as psoriasis and hidradenitis suppurativa.
261Q00000X | Gastroenterology | Prescribes adalimumab for inflammatory bowel disease such as Crohn disease and ulcerative colitis.
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|
M05.79 | Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or system involvement | Common indication for adalimumab to control systemic inflammatory activity. |
L40.0 | Psoriasis vulgaris | Psoriatic skin disease often treated with adalimumab when topical/systemic therapies are inadequate.
L73.2 | Hidradenitis suppurativa | Moderate to severe disease may be an indication for adalimumab therapy.
K50.90 | Crohn's disease, unspecified, without complications | Crohn disease is a gastrointestinal inflammatory condition treated with adalimumab for induction and maintenance.
M45.9 | Ankylosing spondylitis, site unspecified | A spondyloarthropathy for which adalimumab is an approved biologic therapy.
M07.3 | Psoriatic juvenile arthropathy | Pediatric/young adult inflammatory arthritis associated with psoriasis treated with biologic agents including adalimumab.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | Used when a clinician administers a subcutaneous injection of a biologic agent in a clinic setting alongside billing the drug itself. |
99401 | Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (15 minutes) | Used when counseling regarding self-injection technique, drug risks, and monitoring is provided during a dedicated counseling visit.
99070 | Supplies and materials (eg, drugs, sutures, dressings), provided by the physician over and above those usually included with the office visit or other services | Used to bill for ancillary supplies used in administration when payor policy permits separate supply charges.
G0008 | Administration of influenza virus vaccine (separate for Medicare) — note: example of vaccine administration reporting conventions | Included as an example of administration reporting conventions when payors require specific administration codes for injectable therapies; not typically used for adalimumab but useful in workflows where separate administration codes are required.
96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | Not directly used for subcutaneous adalimumab but listed when an associated IV infusion or observation service occurs in the same encounter.